Clearside Biomedical
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $492 | $2,330 | $306 | $1,038 |
Gross Profit | 408 | 2,082 | 157 | 1,038 |
EBITDA | -3,568 | -4,750 | -4,648 | -5,156 |
EBIT | -3,652 | -4,835 | -4,727 | -5,231 |
Net Income | -4,495 | -8,223 | -7,306 | -7,688 |
Net Change In Cash | 492 | 2,330 | 306 | 1,038 |
Free Cash Flow | -4,729 | -5,830 | -5,698 | -5,966 |
Cash | 9,376 | 13,628 | 20,020 | 13,888 |
Basic Shares | 5,189 | 5,128 | 5,056 | 4,983 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,664 | $8,226 | $1,327 | $29,575 |
Gross Profit | 1,515 | 7,871 | 1,123 | 29,575 |
EBITDA | -24,347 | -23,058 | -29,463 | 554 |
EBIT | -24,573 | -23,125 | -29,608 | 376 |
Net Income | -34,352 | -32,485 | -32,947 | 376 |
Net Change In Cash | 1,664 | 8,226 | 1,327 | 29,575 |
Cost of Revenue | 17,722 | 13,049 | ||
Free Cash Flow | -25,675 | -19,912 | -13,611 | -10,733 |
Cash | 20,020 | 28,920 | 48,258 | 30,436 |
Basic Shares | 4,920 | 4,120 | 4,013 | 3,993 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.10 |
